Liposomal Bupivacaine Clinical Trials

11 recruitingLast updated: May 21, 2026

There are 11 actively recruiting liposomal bupivacaine clinical trials across 2 countries. Studies span Not Applicable, Phase 3, Phase 4. Top locations include Beijing, Beijing Municipality, China, Guangzhou, Guangdong, China, Hong Kong, Hong Kong, Hong Kong. Updated daily from ClinicalTrials.gov.


Liposomal Bupivacaine Trials at a Glance

11 actively recruiting trials for liposomal bupivacaine are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Beijing, Guangzhou, and Hong Kong. Lead sponsors running liposomal bupivacaine studies include Beijing Tiantan Hospital, Nanjing First Hospital, Nanjing Medical University, and Huazhong University of Science and Technology.

Browse liposomal bupivacaine trials by phase

About Liposomal Bupivacaine Clinical Trials

Looking for clinical trials for Liposomal Bupivacaine? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Liposomal Bupivacaine trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Liposomal Bupivacaine clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block

Postoperative PainLiposomal Bupivacaine
Tianjin First Central Hospital86 enrolled1 locationNCT07577934
Recruiting
Not Applicable

Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal Block Combined With IPACK Block in Total Knee Arthroplasty

Nerve BlockLiposomal BupivacaineTotal Knee Anthroplasty+1 more
Huazhong University of Science and Technology90 enrolled1 locationNCT07509866
Recruiting
Not Applicable

The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery

Laparoscopic SurgeryLiposomal BupivacaineTransversus Abdominis Plane Block
Beijing Tiantan Hospital318 enrolled1 locationNCT07458282
Recruiting
Not Applicable

The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology

Laparoscopic SurgeryLiposomal BupivacaineTransversus Abdominis Plane Block+1 more
Beijing Tiantan Hospital110 enrolled1 locationNCT07458295
Recruiting
Not Applicable

The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery

Laparoscopic SurgeryLiposomal BupivacaineLocal Infiltration
Beijing Tiantan Hospital190 enrolled1 locationNCT07458256
Recruiting
Not Applicable

The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery

Pain ManagementVideo-assisted Thoracoscopic Surgery (VATS)Liposomal Bupivacaine+1 more
Beijing Tiantan Hospital100 enrolled1 locationNCT07432711
Recruiting
Not Applicable

The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery

Pain ManagementVideo-assisted Thoracoscopic Surgery (VATS)Liposomal Bupivacaine+1 more
Beijing Tiantan Hospital134 enrolled1 locationNCT07441902
Recruiting
Not Applicable

Liposomal Bupivacaine Versus Ropivacaine for Preperitoneal Infiltration Analgesia in Upper Abdominal Laparotomy

AnalgesiaLiposomal BupivacainePreperitoneal Infiltration
Qilu Hospital of Shandong University146 enrolled1 locationNCT07271979
Recruiting
Phase 3

Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty

Pain, PostoperativeTotal Knee ArthroplastyLiposomal Bupivacaine+2 more
The University of Hong Kong177 enrolled1 locationNCT06740214
Recruiting
Phase 4

Determination of the Optimal Volume of Liposomal Bupivacaine in Adductor Canal Block for Knee Joint Surgery

Optimal Volume of Liposomal Bupivacaine
Nanjing First Hospital, Nanjing Medical University63 enrolled1 locationNCT06942689
Recruiting
Phase 3

Liposomal Bupivacaine vs Ropivacaine for TAPBs

postoperative analgesiaLiposomal BupivacaineAbdominal Tumor+1 more
Sun Yat-sen University74 enrolled1 locationNCT06430112